Martínez, Eriel, Silvera, Risset, Campos, Javier, Rodríguez, Boris Luis, Silva, Yussuan, Suzarte, Edith, Ledón, Talena, Marrero, Karen, and Fando, Rafael
Live attenuated vaccine candidates of Vibrio cholerae are the most promising option to develop an effective vaccine against cholera disease. However, the releasing to the environment of millions of vibrio cells during vaccination campaigns entails the risk that attenuated strains reacquire the cholera toxin genes by a horizontal gene transfer mechanism. This work describes the construction of a new generation of vaccine candidates with improved environmental safety features by deletion of the mshA gene from the chromosome of the Vibrio cholerae vaccine strains. This gene encodes the main subunit of the mannose sensitive hemagglutinin (MSHA) type 4 pilus, which functions as a receptor of the filamentous phage VGJφ. The phage VGJφ is able to transduce the genes encoding cholera toxin, the main virulence factor of V. cholerae, through a specific and efficient mechanism. Therefore, the MSHA pilus is a port of entry for the genes of cholera toxin by horizontal gene transfer. The strategy used to delete the mshA gene was the genetic replacement of the wild type gene by an internal deleted copy of the gene contained in a suicide vector. The resultant ΔmshA mutants showed full resistance to the infection with VGJφ, thus, they are unable to reacquire the cholera toxin encoding genes through the mechanism mediated by this phage. Besides, these mutants kept unaltered the features of their parental strains that are desirables for an effective vaccine candidate, such as the morphology, growing rate, motility and ability to colonize the small intestine in the suckling mouse cholera model. [ABSTRACT FROM AUTHOR]